. . . . . . . "[Breast cancer xenografts (MDA-MB-436) treated with TF or VEGF-specific agents demonstrated significant inhibition in tumour growth (VEGFsiRNA 61%; final volume: 236.2 � 23.2 mm(3) vs TFshRNA 89%; 161.9 � 17.4 mm(3) vs combination 93%; 136.3 � 9.2 mm(3) vs control 400.4 � 32.7 mm(3); P < 0.005).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:17:13+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .